HLIEX
Price
$25.56
Change
+$0.07 (+0.27%)
Updated
Jul 2 closing price
Net Assets
44.32B
VIVAX
Price
$69.73
Change
+$0.05 (+0.07%)
Updated
Jul 2 closing price
Net Assets
188.77B
Interact to see
Advertisement

HLIEX vs VIVAX

Header iconHLIEX vs VIVAX Comparison
Open Charts HLIEX vs VIVAXBanner chart's image
JPMorgan Equity Income I
Price$25.56
Change+$0.07 (+0.27%)
VolumeN/A
Net Assets44.32B
Vanguard Value Index I
Price$69.73
Change+$0.05 (+0.07%)
VolumeN/A
Net Assets188.77B
HLIEX vs VIVAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
HLIEX vs. VIVAX commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLIEX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. HLIEX (44.3B). VIVAX pays higher dividends than HLIEX: VIVAX (2.06) vs HLIEX (1.67). HLIEX was incepted earlier than VIVAX: HLIEX (38 years) vs VIVAX (33 years). HLIEX (0.70) is less costly to investors than VIVAX (0.17). HLIEX is a more actively managed with annual turnover of: 20.00 vs. VIVAX (9.00). VIVAX has a lower initial minimum investment than HLIEX: VIVAX (3000) vs HLIEX (1000000). VIVAX annual gain was more profitable for investors over the last year : 11.48 vs. HLIEX (8.28). VIVAX return over 5 years is better than : 78.98 vs. HLIEX (65.73).
HLIEXVIVAXHLIEX / VIVAX
Total Expense Ratio0.700.17412%
Annual Report Gross Expense Ratio0.700.17412%
Fund Existence38 years33 years-
Gain YTD7.4085.527134%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets44.3B189B23%
Annual Yield % from dividends1.672.0681%
Returns for 1 year8.2811.4872%
Returns for 3 years22.6434.2966%
Returns for 5 years65.7378.9883%
Returns for 10 years108.94113.3796%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ONCY0.780.03
+4.55%
Oncolytics Biotech
RMR17.220.28
+1.65%
RMR Group (The)
REGCO22.600.24
+1.07%
Regency Centers Corp
SUPN32.090.27
+0.85%
Supernus Pharmaceuticals
CROX106.74-0.39
-0.36%
Crocs